Dr. Khaled Elubous is an Assistant Professor of Ophthalmology at The Hashemite University, Jordan. He completed a fellowship at McGill University, Canada, from 2022 to 2024, gaining advanced training in ophthalmic clinical practice, surgery, and academic research. Dr. Elubous has a broad academic interest in ophthalmology, with particular interests in glaucoma, cataract and anterior segment surgery, retinal diseases, and the clinical application of emerging ophthalmic therapies. His research focuses on clinically relevant questions in ophthalmology, including treatment outcomes, surgical innovations, safety and complications of intravitreal therapies, and evidence-based approaches to patient care. He has authored and co-authored peer-reviewed publications and has a strong interest in systematic reviews, meta-analyses, and clinical research methodology. His academic work aims to critically evaluate current evidence and translate research findings into meaningful improvements in ophthalmic practice and patient outcomes.
Dr. Khaled Elubous is an Assistant Professor of Ophthalmology at The Hashemite University, Jordan. He completed a fellowship at McGill University, Canada, from 2022 to 2024, gaining advanced training in ophthalmic clinical practice, surgery, and academic research. Dr. Elubous has a broad academic interest in ophthalmology, with particular interests in glaucoma, cataract and anterior segment surgery, retinal diseases, and the clinical application of emerging ophthalmic therapies. His research focuses on clinically relevant questions in ophthalmology, including treatment outcomes, surgical innovations, safety and complications of intravitreal therapies, and evidence-based approaches to patient care. He has authored and co-authored peer-reviewed publications and has a strong interest in systematic reviews, meta-analyses, and clinical research methodology. His academic work aims to critically evaluate current evidence and translate research findings into meaningful improvements in ophthalmic practice and patient outcomes.